Finance

Lists
1177:HKG
Sino Biopharmaceutical Ltd
၅.၂၅ HK$
-၀.၃၈%
(-၀.၀၂၀) 1D
အောက် ၁၆, GMT+၈ ၁၆:၀၈:၁၄  ·   HKD
All symbols
SymbolPriceChange% Change
Generating top insights for 1177...
Open
၅.၄၀ HK$
High
၅.၅၀ HK$
Low
၅.၁၄ HK$
Mkt. cap
ဋေ ၉.၈၁ ထ
Avg. vol.
၆.၉၃ ကုဋေ
Volume
၈.၃၉ ကုဋေ
Dividend
၂.၂၉%
Quarterly dividend
၀.၀၃ HK$
Ex-dividend date
၂၀၂၅ ဩ ၂၉
P/E ratio
၃၃.၈၆
52-wk high
၇.၇၉ HK$
52-wk low
၄.၁၉ HK$
EPS
၀.၁၆ HK$
Shares outstanding
ဋေ ၁.၂၆ ထ
No. of employees
၂ သောင်း
Open
၅.၄၀ HK$
High
၅.၅၀ HK$
Low
၅.၁၄ HK$
Mkt. cap
ဋေ ၉.၈၁ ထ
Avg. vol.
၆.၉၃ ကုဋေ
Volume
၈.၃၉ ကုဋေ
Dividend
၂.၂၉%
Quarterly dividend
၀.၀၃ HK$
Ex-dividend date
၂၀၂၅ ဩ ၂၉
P/E ratio
၃၃.၈၆
52-wk high
၇.၇၉ HK$
52-wk low
၄.၁၉ HK$
EPS
၀.၁၆ HK$
Shares outstanding
ဋေ ၁.၂၆ ထ
No. of employees
၂ သောင်း
News stories
From web sources and news partners
StreetInsider
StreetInsider
·
ပြီးခဲ့သည့် ၆ မိနစ်
Williams-Sonoma appoints NYSE Group president to its board
GlobeNewswire
GlobeNewswire
·
ပြီးခဲ့သည့် ၁ နာရီ
QTREX Regains Compliance with Nasdaq Minimum Bid Price Requirement
Profile
Sino Biopharmaceutical Limited, shortly SBP Group, is a pharmaceutical conglomerate in China. The Company was listed on the Hong Kong Stock Exchange in 2000 and included in 2013 as a constituent stock of MSCI Global Standard Indices – MSCI China Index, Hang Seng Index in 2018, Hang Seng China Enterprises Index in 2019, and Hang Seng Connect Biotech 50 Index and Hang Seng China 25 Index in 2020. The Group’s principal subsidiaries include: Chia Tai Tianqing Pharmaceutical Group Co. Ltd., Beijing Tide Pharmaceutical Co. Ltd., Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd., Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd., Jiangsu Chia Tai Qingjiang Pharmaceutical Co., Ltd. and invoX Pharma Limited. Its products including biopharmaceutical and chemical medicines are used in a host of therapeutic areas, such as tumors, liver diseases, respiratory system diseases and surgery/analgesia. Wikipedia
About Sino Biopharmaceutical Ltd
CEOLi Yi
Employees၂.၂၈ သောင်း
Founded၂၀၀၀
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
Revenue
၇၁၂.၉၉ ဋေ
၇၁၂.၉၉ ဋေ
၉၇၂.၂၂ ဋေ
၉၇၂.၂၂ ဋေ
Cost of goods sold
၁၃၁.၃၃ ဋေ
၁၃၁.၃၃ ဋေ
၁၆၄.၈၃ ဋေ
၁၆၄.၈၃ ဋေ
Cost of revenue
၁၃၁.၃၃ ဋေ
၁၃၁.၃၃ ဋေ
၁၆၄.၈၃ ဋေ
၁၆၄.၈၃ ဋေ
Research and development expenses
၂၉၃.၃၁ ဋေ
၂၉၃.၃၁ ဋေ
၁၅၄.၀၀ ဋေ
၁၅၄.၀၀ ဋေ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၂၇၉.၆၇ ဋေ
၂၇၉.၆၇ ဋေ
၃၁၁.၄၈ ဋေ
၃၁၁.၄၈ ဋေ
Operating expense
၄၃၇.၅၁ ဋေ
၄၃၇.၅၁ ဋေ
၄၇၆.၈၀ ဋေ
၄၇၆.၈၀ ဋေ
Total operating expenses
၅၆၈.၈၅ ဋေ
၅၆၈.၈၅ ဋေ
၆၄၁.၆၃ ဋေ
၆၄၁.၆၃ ဋေ
Operating income
၁၄၄.၁၄ ဋေ
၁၄၄.၁၄ ဋေ
၃၃၀.၅၈ ဋေ
၃၃၀.၅၈ ဋေ
Other non operating income
၉.၈၀ ကုဋေ
၉.၈၀ ကုဋေ
၇.၆၆ ကုဋေ
၇.၆၆ ကုဋေ
EBT including unusual items
၄၈.၈၂ ကုဋေ
၄၈.၈၂ ကုဋေ
၃၆၆.၉၇ ဋေ
၃၆၆.၉၇ ဋေ
EBT excluding unusual items
၁၅၅.၀၇ ဋေ
၁၅၅.၀၇ ဋေ
၃၅၅.၅၃ ဋေ
၃၅၅.၅၃ ဋေ
Income tax expense
၃၂.၃၈ ကုဋေ
၃၂.၃၈ ကုဋေ
၅၉.၈၀ ကုဋေ
၅၉.၈၀ ကုဋေ
Effective tax rate
၆၆.၃၂%
၆၆.၃၂%
၁၆.၂၉%
၁၆.၂၉%
Other operating expenses
-၁၃၅.၄၇ ဋေ
-၁၃၅.၄၇ ဋေ
၁၁.၃၂ ကုဋေ
၁၁.၃၂ ကုဋေ
Net income
-၅၂.၂၆ ကုဋေ
-၅၂.၂၆ ကုဋေ
၁၇၁.၇၃ ဋေ
၁၇၁.၇၃ ဋေ
Net profit margin
-၇.၃၃%
-၇.၃၃%
၁၇.၆၆%
၁၇.၆၆%
Earnings per share
-
-
-
-
Interest and investment income
၁၉.၆၄ ကုဋေ
၁၉.၆၄ ကုဋေ
၂၅.၀၁ ကုဋေ
၂၅.၀၁ ကုဋေ
Interest expense
-၇.၇၆ ကုဋေ
-၇.၇၆ ကုဋေ
-၈.၄၈ ကုဋေ
-၈.၄၈ ကုဋေ
Net interest expenses
၁၁.၈၈ ကုဋေ
၁၁.၈၈ ကုဋေ
၁၆.၅၃ ကုဋေ
၁၆.၅၃ ကုဋေ
Depreciation and amortization charges
-
-
-
-
EBITDA
၁၆၅.၈၄ ဋေ
၁၆၅.၈၄ ဋေ
၃၅၆.၅၅ ဋေ
၃၅၆.၅၅ ဋေ
Gain or loss from assets sale
-၅.၅၈ သန်း
-၅.၅၈ သန်း
-
-
AI content may include mistakes. Learn more
Google အက်ပ်များ